The Financial Express

Avance Technologies Share Price

Click to deselect and select. Feb 13, 2026, 10:57 PM IST AvanceTechnologies - Board Meeting Outcome for Outcome Of Board Meeting For Declaration Of Un-Audited Financial Results (Stan Feb 13, 2026, ...
The Financial Express

Avance Technologies Share Price Announcement

Feb 13, 2026, 10:57 PM IST AvanceTechnologies - Board Meeting Outcome for Outcome Of Board Meeting For Declaration Of Un-Audited Financial Results (Stan Feb 13, 2026, 10:50 PM IST AvanceTechnologies - ...
The Business Journals

Avance Biosciences opens 75K-SF biomanufacturing facility in northwest Houston

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The 75,000-square-foot building ...
Nasdaq

FDA Approves Axogen's AVANCE Nerve Allograft For Peripheral Nerve Repair

(RTTNews) - Axogen, Inc. (AXGN) announced that the U.S. Food and Drug Administration has approved the Biologics License Application (BLA) for AVANCE, an acellular nerve allograft (arwx). AXGN closed ...
Nasdaq

Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx)

ALACHUA, Fla. and TAMPA, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical technologies for the restoration of ...
Monthly Prescribing Reference

Acellular Nerve Allograft Avance Approved for Nerve Repair

Clinical trial findings showed Avance was noninferior to a collagen nerve cuff for returning sensory function in patients with nerve injuries in the hand. The Food and Drug Administration (FDA) has ...
BioWorld

Axogen's Avance secures FDA approval for nerve repair

The U.S. FDA granted accelerated approval for the Biologics License Application for Axogen Inc.'s Avance, an acellular nerve allograft that serves as a scaffold for nerve regrowth, for treatment of ...
GEN

Potency and Cell-Based Assay Center Opened by Avance Biosciences

Avance Biosciences opened its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility designed to expand and centralize the company’s capabilities in potency and functional ...
Reuters

FDA approves Axogen's nerve repair graft

Dec 3 (Reuters) - The U.S. Food and Drug Administration has approved Axogen's (AXGN.O), opens new tab nerve repair graft, the health regulator said on Wednesday, paving the way for 12 years of ...
PE Hub

Avance invests in nutritional chocolate maker Barchemy

Barchemy founder and CEO Larry Toscano will retain a significant ownership stake and continue to lead the company Barchemy was founded in 2015 Avance Investment Management has made an investment in ...
Mint

Penny stock under ₹5 hits upper circuit for 43rd day in a row; do you own?

Avance Technologies' share price has surged to ₹2.33, hitting its 52-week high for the 43rd consecutive session. The stock has gained 348% from its low of ₹0.52 in April 2025, delivering significant ...
Mint

Penny stock under ₹5 hits upper circuit for fifth straight session; here’s why

Avance Technologies share price hit upper circuit for the fifth straight trading session to touch a 52-week high on Monday amid heavy buying volumes. The small-cap penny stock gained as much as 2% to ...